154 related articles for article (PubMed ID: 9354237)
1. 10-Formyl-5,8,10-trideazafolic acid (10-formyl-TDAF): a potent inhibitor of glycinamide ribonucleotide transformylase.
Boger DL; Haynes NE; Kitos PA; Warren MS; Ramcharan J; Marolewski AE; Benkovic SJ
Bioorg Med Chem; 1997 Sep; 5(9):1817-30. PubMed ID: 9354237
[TBL] [Abstract][Full Text] [Related]
2. Abenzyl 10-formyl-trideazafolic acid (abenzyl 10-formyl-TDAF): an effective inhibitor of glycinamide ribonucleotide transformylase.
Boger DL; Haynes NE; Warren MS; Ramcharan J; Marolewski AE; Kitos PA; Benkovic SJ
Bioorg Med Chem; 1997 Sep; 5(9):1847-52. PubMed ID: 9354240
[TBL] [Abstract][Full Text] [Related]
3. 10-(2-benzoxazolcarbonyl)-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid: a potential inhibitor of GAR transformylase and AICAR transformylase.
Marsilje TH; Hedrick MP; Desharnais J; Capps K; Tavassoli A; Zhang Y; Wilson IA; Benkovic SJ; Boger DL
Bioorg Med Chem; 2003 Oct; 11(20):4503-9. PubMed ID: 13129586
[TBL] [Abstract][Full Text] [Related]
4. 10-Formyl-5,10-dideaza-acyclic-5,6,7,8-tetrahydrofolic acid (10-formyl-DDACTHF): a potent cytotoxic agent acting by selective inhibition of human GAR Tfase and the de novo purine biosynthetic pathway.
Marsilje TH; Labroli MA; Hedrick MP; Jin Q; Desharnais J; Baker SJ; Gooljarsingh LT; Ramcharan J; Tavassoli A; Zhang Y; Wilson IA; Beardsley GP; Benkovic SJ; Boger DL
Bioorg Med Chem; 2002 Aug; 10(8):2739-49. PubMed ID: 12057663
[TBL] [Abstract][Full Text] [Related]
5. Functionalized analogues of 5,8,10-trideazafolate: development of an enzyme-assembled tight binding inhibitor of GAR Tfase and a potential irreversible inhibitor of AICAR Tfase.
Boger DL; Haynes NE; Warren MS; Ramcharan J; Kitos PA; Benkovic SJ
Bioorg Med Chem; 1997 Sep; 5(9):1839-46. PubMed ID: 9354239
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of simplified alpha-keto heterocycle, trifluoromethyl ketone, and formyl substituted folate analogues as potential inhibitors of GAR transformylase and AICAR transformylase.
Marsilje TH; Hedrick MP; Desharnais J; Tavassoli A; Zhang Y; Wilson IA; Benkovic SJ; Boger DL
Bioorg Med Chem; 2003 Oct; 11(20):4487-501. PubMed ID: 13129585
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of fluoronitrophenyl substituted folate analogues as potential inhibitors of GAR transformylase and AICAR transformylase.
Boger DL; Marsilje TH; Castro RA; Hedrick MP; Jin Q; Baker SJ; Shim JH; Benkovic SJ
Bioorg Med Chem Lett; 2000 Jul; 10(13):1471-5. PubMed ID: 10888335
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of 10-CF3CO-DDACTHF analogues and derivatives as inhibitors of GAR Tfase and the de novo purine biosynthetic pathway.
Desharnais J; Hwang I; Zhang Y; Tavassoli A; Baboval J; Benkovic SJ; Wilson IA; Boger DL
Bioorg Med Chem; 2003 Oct; 11(20):4511-21. PubMed ID: 13129587
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of N-[4-[5-(2,4-diamino-6-oxo-1,6-dihydropyrimidin-5-yl)-2-(2,2,2-trifluoroacetyl)pentyl]benzoyl]-L-glutamic acid as a potential inhibitor of GAR Tfase and the de novo purine biosynthetic pathway.
Cheng H; Hwang I; Chong Y; Tavassoli A; Webb ME; Zhang Y; Wilson IA; Benkovic SJ; Boger DL
Bioorg Med Chem; 2005 May; 13(10):3593-9. PubMed ID: 15848772
[TBL] [Abstract][Full Text] [Related]
10. Functionalized analogues of 5,8,10-trideazafolate as potential inhibitors of GAR Tfase or AICAR Tfase.
Boger DL; Haynes NE; Warren MS; Gooljarsingh LT; Ramcharan J; Kitos PA; Benkovic SJ
Bioorg Med Chem; 1997 Sep; 5(9):1831-8. PubMed ID: 9354238
[No Abstract] [Full Text] [Related]
11. Design, synthesis, and biological evaluation of 10-methanesulfonyl-DDACTHF, 10-methanesulfonyl-5-DACTHF, and 10-methylthio-DDACTHF as potent inhibitors of GAR Tfase and the de novo purine biosynthetic pathway.
Cheng H; Chong Y; Hwang I; Tavassoli A; Zhang Y; Wilson IA; Benkovic SJ; Boger DL
Bioorg Med Chem; 2005 May; 13(10):3577-85. PubMed ID: 15848770
[TBL] [Abstract][Full Text] [Related]
12. Conformationally restricted analogues designed for selective inhibition of GAR Tfase versus thymidylate synthase or dihydrofolate reductase.
Boger DL; Labroli MA; Marsilje TH; Jin Q; Hedrick MP; Baker SJ; Shim JH; Benkovic SJ
Bioorg Med Chem; 2000 May; 8(5):1075-86. PubMed ID: 10882019
[TBL] [Abstract][Full Text] [Related]
13. Rational design, synthesis, evaluation, and crystal structure of a potent inhibitor of human GAR Tfase: 10-(trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrofolic acid.
Zhang Y; Desharnais J; Marsilje TH; Li C; Hedrick MP; Gooljarsingh LT; Tavassoli A; Benkovic SJ; Olson AJ; Boger DL; Wilson IA
Biochemistry; 2003 May; 42(20):6043-56. PubMed ID: 12755606
[TBL] [Abstract][Full Text] [Related]
14. New insights into inhibitor design from the crystal structure and NMR studies of Escherichia coli GAR transformylase in complex with beta-GAR and 10-formyl-5,8,10-trideazafolic acid.
Greasley SE; Yamashita MM; Cai H; Benkovic SJ; Boger DL; Wilson IA
Biochemistry; 1999 Dec; 38(51):16783-93. PubMed ID: 10606510
[TBL] [Abstract][Full Text] [Related]
15. A quantum chemical study on the mechanism of glycinamide ribonucleotide transformylase inhibitor: 10-Formyl-5,8,10-trideazafolic acid.
Qiao QA; Jin Y; Yang C; Zhang Z; Wang M
Biophys Chem; 2005 Dec; 118(2-3):78-83. PubMed ID: 16198047
[TBL] [Abstract][Full Text] [Related]
16. Unexpected formation of an epoxide-derived multisubstrate adduct inhibitor on the active site of GAR transformylase.
Greasley SE; Marsilje TH; Cai H; Baker S; Benkovic SJ; Boger DL; Wilson IA
Biochemistry; 2001 Nov; 40(45):13538-47. PubMed ID: 11695901
[TBL] [Abstract][Full Text] [Related]
17. Human AICAR transformylase: role of the 4-carboxamide of AICAR in binding and catalysis.
Wall M; Shim JH; Benkovic SJ
Biochemistry; 2000 Sep; 39(37):11303-11. PubMed ID: 10985775
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and evaluation of potential GAR and AICAR transformylase inhibitors.
Boger DL; Kochanny MJ; Cai H; Wyatt D; Kitos PA; Warren MS; Ramcharan J; Gooljarsingh LT; Benkovic SJ
Bioorg Med Chem; 1998 Jun; 6(6):643-59. PubMed ID: 9681131
[No Abstract] [Full Text] [Related]
19. Crystal structures of human GAR Tfase at low and high pH and with substrate beta-GAR.
Zhang Y; Desharnais J; Greasley SE; Beardsley GP; Boger DL; Wilson IA
Biochemistry; 2002 Dec; 41(48):14206-15. PubMed ID: 12450384
[TBL] [Abstract][Full Text] [Related]
20. Discovery of AICAR Tfase inhibitors that disrupt requisite enzyme dimerization.
Capps KJ; Humiston J; Dominique R; Hwang I; Boger DL
Bioorg Med Chem Lett; 2005 Jun; 15(11):2840-4. PubMed ID: 15911265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
